⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12643175 | 0.67 | — | — | |
| SCHEMBL5533502 | 0.53 | — | — | |
| SCHEMBL3248263 | 0.52 | — | — | |
| SCHEMBL15737899 | 0.52 | — | — | |
| SCHEMBL2550303 | 0.50 | — | — | |
| SCHEMBL6765508 | 0.49 | — | — | |
| SCHEMBL12865901 | 0.46 | — | — | |
| SCHEMBL141953 | 0.44 | — | — | |
| SCHEMBL13157175 | 0.44 | — | — | |
| SCHEMBL2759885 | 0.44 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7906554-B2 | Combination chemotherapy compositions and methods | NOVOGEN RESEARCH PTY LTD (AU) | 2011-03-15 | — | — | US | disclosed |
| US-20100152284-A1 | PREVENTION AND REVERSAL OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY | NOVOGEN RESEARCH PTY LTD (AU) | 2010-06-17 | — | — | US | disclosed |
| US-20080069900-A1 | Combination chemotherapy compositions and methods | NOVOGEN RESEARCH PTY LTD | 2008-03-20 | — | — | US | disclosed |
| US-20070244075-A1 | Isoflavonoid Prodrugs, Compositons Thereof and Therapeutic Methods Involving Same | NOVOGEN RESEARCH PTY LTD | 2007-10-18 | — | — | US | disclosed |